目的:检测抗原处理相关转运蛋白(transporters associated with antigen processing,TAP)和HIA—I类分子在恶性黑素瘤组织中的表达。方法:应用免疫组织化学方法检测77例恶性黑素瘤组织TAP1、TAP2和HLA~I类分子的表达,并进行半定量分析,以20例色素痣组织作为对照研究。结果:在77例恶性黑素瘤组织中,TAP1、TAP2和HLA—I类分子的阳性表达率分别为23.38%、11.69%和63.64%,HLA—I类分子的表达与TAP1和TAP2成正相关;而TAP1、TAP2和HIJA—I类分子几乎在所有的色素痣组织中都为阳性表达。结论:在恶性黑素瘤组织中TAP1、TAP2和HLA—I类分子的表达水平下降,可能与人恶性黑素瘤细胞的免疫逃逸表型有关。TAP1和TAP2的表达下降可能是导致HIA—I类分子表达下降的重要原因。
Objective: To investigate the expression of TAP and HLA class I antigen in malignant melanoma (MM). Methods: The expression of TAP and class- 1 antigen was measured by immunohistochemistry method and the correlation between the expression of TAP and class - 1 antigen was compared in 77 patients with MM. Samples from naevi of 20 cases were used as control. Results: Positive TAP1, TAP2 and HLA class I antigen immunostaining were observed in 23%, 12% and 64% of MM lesions respectively, and the expression of HLA class- I was positively correlated with that of TAP1 and TAP2. The expression of these molecules was positive in all of the pigmented naevi lesions. Conclusion: Our data suggest that reduced TAP1, TAP2 and HLA class - I antigen protein expression in MM may contribute to the immune escape phenotype of human melanoma cells, and the main cause of reduced HLA class - I expression may be due to the decreasing of TAP1 and TAP2 levels.